MeSH tree: D23.529.374.465.513
Researchers at Tel Aviv University have developed one of the first experimental models that faithfully reproduces eosinophilic gastritis (EoG), a rare but increasingly recognized allergic disease of the stomach. Using this ...
Jul 13, 2026
0
6
For the first time, patients have received a new injection for chronic obstructive pulmonary disease (COPD), thanks to research by King's College London.
Jun 25, 2026
0
4
The U.S. Food and Drug Administration has approved Sanofi and Regeneron's Dupixent (dupilumab) for the treatment of children (aged 2 to 11 years) with chronic spontaneous urticaria (CSU).
May 5, 2026
0
7
New research from the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai reveals that patients with moderate-to-severe atopic dermatitis (eczema) who did not initially respond ...
May 13, 2025
0
47
Immune cells play an active and intimate role in directing the growth of human lung tissue during development, researchers find, revolutionizing our understanding of early lung development and the role of immune cells outside ...
Dec 15, 2023
0
504
Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab, according to a yearlong, Phase 3 clinical ...
Jun 20, 2023
0
49
Two phase 3 trials suggest that a 16 week treatment with a drug called lebrikizumab was effective in adults and adolescents with moderate to severe dermatitis, according to a paper published in the New England Journal of ...
Mar 15, 2023
0
60
Researchers at National Jewish Health have identified an immune and lipid profile on the surface of the skin of infants that can predict the development of atopic dermatitis, or eczema, months before the onset of clinical ...
Feb 23, 2023
0
81
Researchers from the BU CTE Center have found that immune-related proteins could help differentiate between neurodegenerative diseases and provide additional candidates for biomarkers or new therapeutic targets.
Nov 21, 2022
0
124
A MedUni Vienna research team has developed a new blood test that indicates a person's status of cellular immunity to SARS-CoV-2 within just 48 hours. This test is particularly relevant for vulnerable patient groups, whose ...
Jul 20, 2022
0
61
